In vitro effect of cyclosporin A on primary and chronic BK polyoma virus infection in Vero E6 cells

Transplant Infectious Disease

Volumn 10, Issue 6, 2008, Pages 385-390

  Acott, P D ^a,b   O'Regan, P A ^a   Lee, S H ^a   Crocker, J F S ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

BK polyoma virus (BKV); Cyclosporin A (CsA); Polyoma virus; Polyomavirus allograft nephropathy (PVAN)

Indexed keywords

CELL PROTEIN; CYCLOSPORIN A; VIRUS DNA;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; VERO CELL; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS INFECTION; VIRUS LOAD; VIRUS REACTIVATION;

ANIMALS; ANTIVIRAL AGENTS; BK VIRUS; CERCOPITHECUS AETHIOPS; CYCLOSPORINE; POLYOMAVIRUS INFECTIONS; TIME FACTORS; TUMOR VIRUS INFECTIONS; VERO CELLS; VIRUS ACTIVATION;

EID: 56549097821     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2008.00330.x     Document Type: Article

References (42)

1. Seikaly M, Ho PL, Emmett L, Tejani A. The 12th annual report of the North American Pediatric Renal Transplant Cooperative Study: renal transplantation from 1987 to 1998. Pediatr Transplant 2001 5 : 215 231.
2. Dharnidharka VR, Stablein DM, Harmon WE. Post-transplant infections now exceed acute rejection as a cause for hospitalization: a report of the NAPRTCS. Am J Transplant 2004 4 : 384 389.
3. Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 2005 79 : 1277 1286.
4. Barber CE, Hewlett TJ, Geldenhuys L, Kiberd BA, Acott PD, Hatchette F. BK virus nephropathy in a heart transplant recipient: case report and review of the literature. Transpl Infect Dis 2006 8 : 113 121.
5. Pendse SS, Vadivel N, Ramos E, et al. BK viral reactivation in cardiac transplant patients: evidence for a double-hit hypothesis. J Heart Lung Transplant 2006 25 : 814 819.
6. Razonable RR, Brown RA, Humar A, et al. PV16000 Study Group. A longitudinal molecular surveillance study of human polyomavirus viremia in heart, kidney, liver, and pancreas transplant patients. J Infect Dis 2005 192 : 1349 1354.
7. Schmid H, Burg M, Kretzler M, Banas B, Grone HJ, Kliem V. BK virus associated nephropathy in native kidneys of a heart allograft recipient. Am J Transplant 2005 5 : 1562 1568.
8. Acott PD, Hirsch HH. BK virus infection, replication and diseases in pediatric kidney transplantation. Pediatr Nephrol 2007 22 : 1243 1250.
9. de Bruyn G, Limaye AP. BK virus-associated nephropathy in kidney transplant recipients. Rev Med Virol 2004 14 : 193 205.
10. Randhawa P, Brennan DC. BK virus infection in transplant recipients: an overview and update. Am J Transplant 2006 6 : 2000 2005.
11. Binet I, Nickeleit V, Hirsch HH, et al. Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation 1999 67 : 918 922.
12. Hodur DM, Mandelbrot D. Immunosuppression and BKV nephropathy. N Engl J Med 2002 347 : 2079 2080.
13. Mengel M, Marwedel M, Radermacher J, et al. Incidence of polyomavirus-nephropathy in renal allografts: influence of modern immunosuppressive drugs. Nephrol Dial Transplant 2003 18 : 1190 1196.
14. Hoyer PF, Vester U. The impact of cyclosporine on the development of immunosuppressive therapy - pediatric transplantation using cyclosporine. Transplant Proc 2004 36 (Suppl 2) : S197 S202.
15. Ramos E, Drachenberg CB, Portocarrero M, et al. BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program. Clin Transplant 2002 143 153.
16. Gonzalez-Pons EJ, Santiago-Delpin EA, Ramos E, et al. Polyoma virus: new or just previously unnoticed? A study of biopsies. Am J Transplant 2005 5 (Suppl 11) : 198.
17. Vahlne A, Larsson PA, Horal P, et al. Inhibition of herpes simplex virus production in vitro by cyclosporin A. Arch Virol 1992 122 : 61 75.
18. Damaso CR, Keller SJ. Cyclosporin A inhibits vaccinia virus replication in vitro. Arch Virol 1994 134 : 303 319.
19. Wainberg MA, Dascal A, Blain N, et al. The effect of cyclosporine A on infection of susceptible cells by human immunodeficiency virus type 1. Blood 1988 72 : 1904 1910.
20. Franke EK, Luban J. Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction. Virology 1996 222 : 279 282.
21. Watashi K, Hijikata M, Hosaka M, Yamaji M, Shimotohno K. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes. Hepatology 2003 38 : 1282 1288.
22. Henry SD, Metselaar HJ, Lonsdale RC, et al. Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-α. Gastroenterology 2006 131 : 1452 1462.
23. Nakagawa M, Sakamoto N, Enomoto N, et al. Specific inhibition of hepatitis C virus replication by cyclosporin A. Biochem Biophys Res Commun 2004 313 : 42 47.
24. Firpi RJ, Zhu H, Morelli G, et al. Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation. Liver Transplant 2006 12 : 51 57.
25. Maniere T, Ethier C, Raymond VA, Andre A, Bilodeau M. Cyclosporin reduces hepatitis C virus replication in the replicon model. J Hepatol 2004 40 (Suppl) : S120.
26. Acott PD, O'Regan PA, Lee SH, Crocker JF. Utilization of Vero cells for primary and chronic BK virus infection. Transplant Proc 2006 38 : 3502 3505.
27. Whiley DM, MacKay IM, Sloots TP. Detection and differentiation of human polyomaviruses JC and BK by LightCycler PCR. J Clin Microbiol 2001 39 : 4357 4361.
28. Drachenberg CB, Papdimitriou JC, Wali R, Cubitt CL, Ramos E. BK polyoma virus allograft nephropathy: ultrastructural features from viral cell entry to lysis. Am J Transplant 2003 3 : 1383 1392.
29. Eash S, Querbes W, Atwood WJ. Infection of vero cells by BK virus is dependent on cavaolae. J Virol 2004 78 : 11583 11590.
30. Eash S, Atwood WJ. Involvement of cytoskeletal components in BK virus infectious entry. J Virol 2005 79 : 11734 11741.
31. McKenzie RC, Epand RM, Johnson DC. Cyclosporine A inhibits herpes simplex virus-induced cell fusion but not virus penetration into cells. Virology 1987 159 : 1 9.
32. Farasati NA, Shapiro R, Vats A, Randhawa P. Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system. Transplantation 2005 79 : 116 118.
33. Randhawa P, Farasati NA, Shapiro R, Hostetler KY. Ether lipid ester derivatives of cidofovir inhibit polyomavirus BK replication in vitro. Antimicrob Agents Chemother 2006 50 : 1564 1566.
34. Rinaldo CH, Hirsch HH. Antivirals for the treatment of polyomavirus BK replication. Expert Rev Anti-Infect Ther 2007 5 : 105 115.
35. Goto K, Watashi K, Murata T, Hishiki T, Hijikata M, Shimotohno K. Evaluation of the anti-hepatitis C virus effects of cyclophilin inhibitors, cyclosporin A, and NIM811. Biochem Biophys Res Commun 2006 343 : 879 884.
36. Watashi K, Ishii N, Hijikata M, et al. Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase. Mol Cell 2005 19 : 111 122.
37. Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2002 3 : 611 623.
38. Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005 5 : 582 594.
39. Hirsch HH, Friman S, Wiecek A, et al. Prospective study of polyomavirus BK viruria and viremia in de novo renal transplantation. Am J Transplant 2007 7 (Suppl 2) : 150 (Abstract 14).
40. Wadei HM, Rule AD, Lewin M, et al. Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN). Am J Transplant 2006 6 (5 Part 1) : 1025 1032.
41. Smith JM, McDonald RA, Finn LS, et al. Polyomavirus nephropathy in pediatric kidney transplant recipients. Am J Transplant 2004 4 : 2109 2117.
42. Shi Y, Moriyama T, Namba Y, et al. Association of treatment with 15-deoxyspergualin and BK virus nephropathy in kidney allograft recipients. Clin Transplant 2007 21 : 502 509.